How should I evaluate and manage a patient with elevated liver function tests (LFTs) and high ferritin levels?

Evaluation and Management of Elevated LFTs and Ferritin

Elevated ferritin in the setting of abnormal liver function tests is most commonly NOT due to iron overload, and you should systematically exclude competing etiologies before pursuing hemochromatosis workup. 1

Initial Diagnostic Approach

Step 1: Measure Transferrin Saturation Immediately

The critical first step is checking transferrin saturation alongside ferritin 1, 2. This single test determines your entire diagnostic pathway:

• High transferrin saturation (>45% in women, >50% in men) → Suggests true iron overload, proceed to hemochromatosis evaluation
• Normal transferrin saturation → Ferritin elevation is likely secondary; do NOT pursue iron overload workup 2

Key clinical pearl: Mildly elevated ferritin is extremely common in NAFLD patients and does NOT indicate increased iron stores 1. In one large study, 21% of NAFLD patients had positive autoantibodies, and elevated ferritin was similarly frequent as an epiphenomenon 1.

Step 2: Complete Standard Liver Etiology Screen

Perform comprehensive evaluation including 3:

• Hepatitis B surface antigen and Hepatitis C antibody (with PCR if positive)
• Autoimmune markers: ANA, ASMA, anti-mitochondrial antibody
• Serum immunoglobulins
• Abdominal ultrasound
• Assess for metabolic syndrome: BMI, blood pressure, lipids, glucose, diabetes status
• Alcohol history (consider phosphatidyl ethanol testing)
• Medication review

Step 3: Interpret Ferritin in Clinical Context

If transferrin saturation is NORMAL 2, 4:

• Ferritin <1000 µg/L with normal liver enzymes → No further iron workup needed; follow in primary care 4, 5
• Investigate alternative causes: metabolic syndrome, NAFLD, alcohol, inflammation (check CRP), malignancy, infection 4, 5

If transferrin saturation is ELEVATED 1:

• Proceed to HFE genetic testing (C282Y and H63D mutations) 1, 6
• C282Y homozygotes with hyperferritinemia can start phlebotomy without further testing 4
• Non-HFE mutations require MRI iron quantification before phlebotomy 4, 7

When to Consider Liver Biopsy

Liver biopsy is indicated in specific scenarios 1, 8, 9:

1. C282Y homozygotes or compound heterozygotes with:

   • Ferritin >1000 µg/L, OR
   • Elevated ALT/AST, OR
   • Age >40 years, OR
   • Hepatomegaly 8, 9

2. Suspected NAFLD with elevated ferritin AND homozygote/compound heterozygote C282Y mutation → Biopsy to assess hepatic iron concentration and exclude significant injury/fibrosis 1

3. Non-HFE iron overload → Biopsy provides diagnostic and prognostic information, determines cellular distribution of iron 8

Important caveat: If ferritin <1000 µg/L without hepatomegaly, thrombocytopenia, or abnormal transaminases, the negative predictive value for advanced fibrosis is 94% 9. Biopsy is NOT needed for diagnosis of iron overload itself 9.

Special Considerations for NAFLD Patients

NAFLD is the most likely diagnosis if metabolic risk factors are present 1, 10, 3:

• Perform fibrosis risk stratification using FIB-4 or NAFLD Fibrosis Score 3
• Elevated autoantibodies (ANA >1:160 or ASMA >1:40) occur in 21% of NAFLD patients and are generally benign 1, 2, 1
• Only pursue autoimmune workup if autoantibodies are associated with hypergammaglobulinemia or very high aminotransferases 1, 2

Common Pitfalls to Avoid

1. Don't reflexively order HFE testing for every elevated ferritin - Check transferrin saturation first 2

2. Don't assume ferritin elevation means iron overload - 90% of hyperferritinemia is NOT due to iron overload 5

3. Don't overlook secondary causes: The ferritin/AST ratio can help distinguish iron overload (high ratio) from liver disease (low ratio) in patients with moderate hyperferritinemia 11

4. Don't forget non-hepatic causes of elevated ferritin: Inflammation, infection, malignancy, metabolic syndrome 4, 5

When to Refer

Refer to gastroenterology/hepatology if 5:

• Ferritin >1000 µg/L
• Cause of elevated ferritin remains unclear after initial workup
• Evidence of advanced fibrosis on non-invasive testing
• Confirmed hemochromatosis requiring management

Bottom line: The combination of normal transferrin saturation with elevated ferritin in the context of metabolic syndrome strongly suggests NAFLD rather than hemochromatosis, and iron depletion therapy is not indicated 2.